Clinical resources, sub-committee information, and related events

HIV/AIDS, Hepatitis C, and STDs

Prevention, testing and treatment resources for HIV/AIDS, hepatitis C and other sexually transmitted diseases.


In the United States, more than 1.7 million individuals are living with HIV/AIDS and roughly one in five living with HIV is unaware of their infection.  Since the first reported case in June 1981, the HIV epidemic has seen a decline in various trends especially that of AIDS cases and deaths which can be attributed, in part, to the wide range of innovative health care and supportive services for people living with HIV. [1] Below you will find information that will assist in improving the care delivered to patients living with HIV/AIDS.

Hepatitis C

Every year, 3–4 million people are infected with the hepatitis C virus. About 150 million people are chronically infected and at risk of developing liver cirrhosis and/or liver cancer. More than 350 000 people die from hepatitis C-related liver diseases every year. Diagnosis of acute infection is often missed because a majority of infected people have no symptoms. There is no vaccine for hepatitis C however, research in this area is ongoing.


The HIV/AIDS, hepatitis C and STD sub-committee meets the first Friday of every month from 12pm-1pm EST. The CHCANYS staff lead is Meital Fried-Almog, Assistant Director, Clinical Excellence and Innovation.

To join the HIV/AIDS, hep C and STD sub-committee, email Meital,